{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:52:23Z","timestamp":1793944343547,"version":"4.8.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015846","name":"Welsh Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012068","name":"Health and Care Research Wales","doi-asserted-by":"publisher","award":["NIHR-FS-19"],"award-info":[{"award-number":["NIHR-FS-19"]}],"id":[{"id":"10.13039\/100012068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Disease activity (DA) monitoring is a standard of care in RA. There is demand for achieving this through patient-reported outcome measures (PROMs). The aim of this study was to determine which items could be used to measure the construct of RA DA, by analysing legacy PROMs, using Rasch measurement theory (RMT) analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Questionnaires including 10 legacy PROMs were sent to people with RA to create original and validation datasets. Items were grouped according to OMERACT domains and analysed using principal component analysis. Based on separate domain RMT analyses of the original dataset, domain-level testlets were assessed to determine which items measure the construct of RA DA. The result was then replicated in confirmatory factor analyses bifactor models and RMT analyses of the validation dataset. Psychometric properties of legacy PROMs were also assessed in the original dataset.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The total sample size was 691 (original: 398, validation: 293). The Patient global domain was split into General health and Disease activity domains under RMT. General health and Fatigue domain items measure a separate construct to the construct of RA DA. A set of 12 Pain, Disease activity, Tenderness and swelling, Physical functioning and Stiffness domain items can be used to measure the construct of RA DA. No legacy PROMs fully fit the Rasch measurement model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>General health and Disease activity domain items are not interchangeable. Twelve items form an item pool that can be used to measure the construct of RA DA. Legacy PROMs should not be recommended for use.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf189","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T20:42:35Z","timestamp":1744058555000},"page":"4902-4912","source":"Crossref","is-referenced-by-count":6,"title":["Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: Rasch measurement theory to identify items and domains"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7743-0234","authenticated-orcid":false,"given":"Tim","family":"Pickles","sequence":"first","affiliation":[{"name":"Centre for Trials Research, Cardiff University , Cardiff,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6675-7335","authenticated-orcid":false,"given":"Mike","family":"Horton","sequence":"additional","affiliation":[{"name":"Psychometric Laboratory for Health Sciences, University of Leeds , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4518-5187","authenticated-orcid":false,"given":"Karl Bang","family":"Christensen","sequence":"additional","affiliation":[{"name":"Section of Biostatistics, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon","family":"Phillips","sequence":"additional","affiliation":[{"name":"Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University , Cardiff,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6934-2928","authenticated-orcid":false,"given":"David","family":"Gillespie","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University , Cardiff,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Mo","sequence":"additional","affiliation":[{"name":"Swansea Bay University Health Board , Port Talbot,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Davies","sequence":"additional","affiliation":[{"name":"Patient and Public Involvement Stakeholders ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Campbell","sequence":"additional","affiliation":[{"name":"Patient and Public Involvement Stakeholders ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4459-8609","authenticated-orcid":false,"given":"Ernest","family":"Choy","sequence":"additional","affiliation":[{"name":"Division of Infection and Immunity, Cardiff University , Cardiff,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"2025090315122601200_keaf189-B1","doi-asserted-by":"crossref","first-page":"e000202","DOI":"10.1136\/rmdopen-2015-000202","article-title":"Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis","volume":"2","author":"Hendrikx","year":"2016","journal-title":"RMD Open"},{"key":"2025090315122601200_keaf189-B2","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1111\/j.1524-4733.2007.00272.x","article-title":"What is sufficient evidence for the reliability and validity of patient-reported outcome measures?","volume":"10","author":"Frost","year":"2007","journal-title":"Value Health"},{"key":"2025090315122601200_keaf189-B3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","author":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"2025090315122601200_keaf189-B4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","article-title":"COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures","volume":"27","author":"Mokkink","year":"2018","journal-title":"Qual Life Res"},{"key":"2025090315122601200_keaf189-B5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures","volume":"27","author":"Prinsen","year":"2018","journal-title":"Qual Life Res"},{"key":"2025090315122601200_keaf189-B6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","article-title":"COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study","volume":"27","author":"Terwee","year":"2018","journal-title":"Qual Life Res"},{"key":"2025090315122601200_keaf189-B7","volume-title":"Probabilistic models for some intelligence and attainment tests","author":"Rasch","year":"1960"},{"key":"2025090315122601200_keaf189-B8","volume-title":"Rasch models in health","author":"Christensen","year":"2013"},{"key":"2025090315122601200_keaf189-B9","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4612-4230-7","volume-title":"Rasch models: foundations, recent developments, and applications","author":"Fischer","year":"1995"},{"key":"2025090315122601200_keaf189-B10","doi-asserted-by":"crossref","first-page":"e002093","DOI":"10.1136\/rmdopen-2021-002093","article-title":"Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelines","volume":"8","author":"Pickles","year":"2022","journal-title":"RMD Open"},{"key":"2025090315122601200_keaf189-B11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"2025090315122601200_keaf189-B12","first-page":"328","article-title":"Sample size and item calibration [or person measure] stability","volume":"7","author":"Linacre","year":"1994","journal-title":"Rasch Measur Trans"},{"key":"2025090315122601200_keaf189-B13","first-page":"S-55","article-title":"RADAI-5 to monitor rheumatoid arthritis","volume":"32","author":"Leeb","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2025090315122601200_keaf189-B14","first-page":"1294","article-title":"Patient-centered rheumatoid arthritis disease activity assessment by a modified RADAI","volume":"35","author":"Leeb","year":"2008","journal-title":"J Rheumatol"},{"key":"2025090315122601200_keaf189-B15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jbspin.2009.04.001","article-title":"A comparison of patient questionnaires and composite indexes in routine care of rheumatoid arthritis patients","volume":"76","author":"Leeb","year":"2009","journal-title":"Joint Bone Spine"},{"key":"2025090315122601200_keaf189-B16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/39.3.321","article-title":"Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index","volume":"39","author":"Fransen","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"2025090315122601200_keaf189-B17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/art.1780380612","article-title":"A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity","volume":"38","author":"Stucki","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2025090315122601200_keaf189-B18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/ard.2007.081984","article-title":"Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting anti-tumour necrosis factor treatment","volume":"67","author":"Veehof","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2025090315122601200_keaf189-B19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.23342","article-title":"Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice","volume":"59","author":"Choy","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025090315122601200_keaf189-B20","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/rheumatology\/kew279","article-title":"Defining criteria for rheumatoid arthritis patient-derived disease activity score that correspond to Disease Activity Score 28 and Clinical Disease Activity Index based disease states and response criteria","volume":"55","author":"Leung","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2025090315122601200_keaf189-B21","first-page":"186","article-title":"Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study","volume":"28","author":"Salaffi","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2025090315122601200_keaf189-B22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3899\/jrheum.081046","article-title":"The uses of disease activity scoring and the physician global assessment of disease activity for managing rheumatoid arthritis in rheumatology practice","volume":"36","author":"Harrington","year":"2009","journal-title":"J Rheumatol"},{"key":"2025090315122601200_keaf189-B23","first-page":"2410","article-title":"A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS\/PAS-II)","volume":"32","author":"Wolfe","year":"2005","journal-title":"J Rheumatol"},{"key":"2025090315122601200_keaf189-B24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/kem364","article-title":"An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures","volume":"47","author":"Pincus","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2025090315122601200_keaf189-B25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/acr.20066","article-title":"RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds","volume":"62","author":"Pincus","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090315122601200_keaf189-B26","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3899\/jrheum.161145","article-title":"Content and construct validity, reliability, and responsiveness of the rheumatoid arthritis flare questionnaire: OMERACT 2016 workshop report","volume":"44","author":"Bartlett","year":"2017","journal-title":"J Rheumatol"},{"key":"2025090315122601200_keaf189-B27","doi-asserted-by":"crossref","first-page":"e000225","DOI":"10.1136\/rmdopen-2015-000225","article-title":"Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA flare core domain set","volume":"2","author":"Bykerk","year":"2016","journal-title":"RMD Open"},{"key":"2025090315122601200_keaf189-B28","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.2011.150656","article-title":"A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: the \u2018FLARE\u2019 instrument","volume":"71","author":"Berthelot","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025090315122601200_keaf189-B29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10067-014-2849-y","article-title":"Patient self-assessment of flare in rheumatoid arthritis: criterion and concurrent validity of the Flare instrument","volume":"35","author":"de Thurah","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2025090315122601200_keaf189-B30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00296-018-4005-5","article-title":"Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis","volume":"38","author":"Fautrel","year":"2018","journal-title":"Rheumatol Int"},{"key":"2025090315122601200_keaf189-B31","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10067-014-2848-z","article-title":"Patient-self assessment of flare in rheumatoid arthritis: translation and reliability of the Flare instrument","volume":"35","author":"Maribo","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2025090315122601200_keaf189-B32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/art.1780350206","article-title":"The rapid assessment of disease activity in rheumatology (radar) questionnaire. Validity and sensitivity to change of a patient self-report measure of joint count and clinical status","volume":"35","author":"Mason","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2025090315122601200_keaf189-B33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/art.1790050309","article-title":"Do self-reported arthritis symptom (RADAR) and health status (AIMS2) data provide duplicative or complementary information?","volume":"5","author":"Mason","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2025090315122601200_keaf189-B34","doi-asserted-by":"crossref","first-page":"e000114","DOI":"10.1136\/rmdopen-2015-000114","article-title":"Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare","volume":"1","author":"Hendrikx","year":"2015","journal-title":"RMD Open"},{"key":"2025090315122601200_keaf189-B35","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/acr.24259","article-title":"Measuring Inflammatory Foot Disease in Rheumatoid Arthritis: development and Validation of the Rheumatoid Arthritis Foot Disease Activity Index-5","volume":"73","author":"Hoque","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090315122601200_keaf189-B36","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/bjsm.2010.080937","article-title":"The Copenhagen Hip and Groin Outcome Score (HAGOS): development and validation according to the COSMIN checklist","volume":"45","author":"Thorborg","year":"2011","journal-title":"Br J Sports Med"},{"key":"2025090315122601200_keaf189-B37","first-page":"86","article-title":"World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials","volume":"41","author":"Boers","year":"1994","journal-title":"J Rheumatol Suppl"},{"key":"2025090315122601200_keaf189-B38","first-page":"1174","article-title":"Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis","volume":"34","author":"Kirwan","year":"2007","journal-title":"J Rheumatol"},{"key":"2025090315122601200_keaf189-B39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14786440109462720","article-title":"LIII. On lines and planes of closest fit to systems of points in space","volume":"2","author":"Pearson","year":"1901","journal-title":"Lond Edinb Dubl Philos Mag J Sci"},{"key":"2025090315122601200_keaf189-B40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1027\/1901-2276.59.3.268","article-title":"Validity and objectivity: reflections on the role and nature of Rasch models","volume":"59","author":"Kreiner","year":"2007","journal-title":"Nord Psychol"},{"key":"2025090315122601200_keaf189-B41","first-page":"348","article-title":"The Rasch model and additive conjoint measurement","volume":"10","author":"Newby","year":"2009","journal-title":"J Appl Meas"},{"key":"2025090315122601200_keaf189-B42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02289343","article-title":"A general approach to confirmatory maximum likelihood factor analysis","volume":"34","author":"J\u00f6reskog","year":"1969","journal-title":"Psychometrika"},{"key":"2025090315122601200_keaf189-B43","volume-title":"Principles and practice of structural equation modelling","author":"Kline","year":"2011","edition":"3rd ed"},{"key":"2025090315122601200_keaf189-B44","author":"Muthen","year":"2017"},{"key":"2025090315122601200_keaf189-B45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/00273171.2012.715555","article-title":"The rediscovery of bifactor measurement models","volume":"47","author":"Reise","year":"2012","journal-title":"Multivariate Behav Res"},{"key":"2025090315122601200_keaf189-B46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1214\/aoms\/1177730491","article-title":"On a test of whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"Ann Math Stat"},{"key":"2025090315122601200_keaf189-B47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1214\/aoms\/1177704172","article-title":"Estimates of location based on rank tests","volume":"34","author":"Hodges","year":"1963","journal-title":"Ann Math Stat"},{"key":"2025090315122601200_keaf189-B48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2307\/1412159","article-title":"The proof and measurement of association between two things","volume":"15","author":"Spearman","year":"1904","journal-title":"Am J Psychol"},{"key":"2025090315122601200_keaf189-B49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf189\/62985047\/keaf189.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/9\/4902\/62985047\/keaf189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/9\/4902\/62985047\/keaf189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:12:41Z","timestamp":1756926761000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/9\/4902\/8117629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,4,22]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf189","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,4,22]]}}}